Imprecision
Author:
Affiliation:
1. From Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference5 articles.
1. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
2. Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
3. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
4. Massive Trial of Celebrex Seeks to Settle Safety Concerns
5. MacDonald TM Hawkey CJ Ford I McMurray JJ Scheiman JM Hallas J Findlay E Grobbee DE Hobbs FD Ralston SH Reid DM Walters MR Webster J Ruschitzka F Ritchie LD Perez-Gutthann S Connolly E Greenlaw N Wilson A Wei L Mackenzie IS. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT) (published online ahead of print October 4 2016). Eur Heart J . doi: 10.1093/eurheartj/ehw387. http://eurheartj.oxfordjournals.org/content/early/2016/10/02/eurheartj.ehw387.long. Accessed October 10 2016.
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials;Journal of Internal Medicine;2022-05-31
2. Eicosanoid Pathway Modulators: Prostaglandins, Prostacyclin, and Thromboxane;Burger's Medicinal Chemistry and Drug Discovery;2021-04-28
3. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective;Biochemical Pharmacology;2020-10
4. Druggable Prostanoid Pathway;Druggable Lipid Signaling Pathways;2020
5. Celecoxib for the treatment of musculoskeletal arthritis;Expert Opinion on Pharmacotherapy;2019-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3